Login / Signup

Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study.

Daniel SchöttleWolfgang JanetzkyDaniel LuedeckeElmar BeckChristoph U CorrellKlaus Wiedemann
Published in: BMC psychiatry (2018)
Treatment with AOM showed satisfying effectiveness in outpatients with further improvement of psychopathology after oral aripiprazole treatment for a considerable duration and even after having achieved clinically judged "stability". Our findings indicate a robust therapeutic effect of AOM and substantiate previous results from randomized controlled trials under real-world routine conditions.
Keyphrases
  • randomized controlled trial
  • end stage renal disease
  • systematic review
  • newly diagnosed
  • ejection fraction
  • bipolar disorder
  • chronic kidney disease
  • clinical trial
  • prognostic factors
  • replacement therapy